pyrene-modified RNAs for the development of new materials and
biotechnological applications.
5ꢀ -Dimethoxytrityl-2ꢀ -O-(pyren-1-ylmethyl)-N-benzoyl-adeno-
sine (3). 4,4ꢀ-Dimethoxytrityl chloride (0.43 g, 1.28 mmol) was
added to a solution of 2 (0.43 g, 0.73 mmol), which was dried
by coevaporation with pyridine three times, in pyridine (4.3 ml).
After stirring for 6 h at room temperature, the solution was
concentrated to near dryness. The residual material was dissolved
in dichloromethane (150 ml) and then washed with water. The
organic phase was dried over Na2SO4 and evaporated to near
dryness. The product 3 was purified with silica gel column
chromatography with dichloromethane containing methanol (9 :
1, CH2Cl2–MeOH, v/v). The appropriate fractions were pooled
and then evaporated to near dryness. The residual solution was
poured into cooled hexane and the precipitate was collected. Yield,
56% (0.29 g); TLC (9 : 1, CH2Cl2–MeOH, v/v), Rf 0.78; 1H-NMR
(DMSO-d6): 3.68 (s, 6H, OCH3), 4.19 (m, 1H, 4ꢀ-CH), 4.60 (m, 1H,
3ꢀ-CH), 4.96 (dd, 1H, 2ꢀ-CH), 5.26 (d, 1H, CH2-pyrene), 5.49 (d,
1H, CH2-pyrene), 5.60 (d, 1H, 3ꢀ-OH), 6.25 (d, 1H, 1ꢀ-CH), 6.79
(d, 4H, aromatic of DMT), 7.15–7.23 (m, total 7H, aromatic of
DMT), 7.33 (d, 2H, aromatic of DMT), 7.56 (dd, 2H, aromatic of
benzoyl), 7.62 (dd, 1H, aromatic of benzoyl), 7.99–8.26 (m, total
11H, aromatic of benzoyl and pyrene), 8.43 (s, 1H, adenine), 8.47
(s, 1H, adenine) and 11.08 (s, 1H, amide).
Experimental
General methods
1H NMR spectra were recorded on a Bruker DRX-500 spec-
trometer, in which chemical shifts (d ppm) were determined on
the basis of a residual peak of solvent (2.49 for DMSO-d6).
Absorption spectra in solution were recorded on a Hitachi U-3500
spectrophotometer, steady-state fluorescence spectra in solution
were measured on a Hitachi F-2500 spectrofluorometer using
excitation and emission slits of 5 nm and corrected. Thermal
denaturations of RNA duplexes were carried out using a Bechman
Coulter Du800. CD spectra were recorded on a JASCO 715
spectropolarimeter.
Syntheses of pyrene modified phosphoramidite monomer according
to Scheme 1
2ꢀ-O-(Pyren-1-ylmethyl)-adenosine (1). 1-Pyrenyl methyl chlo-
ride (1.3 g, 5.16 mmol) was added to a solution of adenosine
(2.1 g, 7.74 mmol) and NaH (0.28 g) in DMF (40 ml). The reaction
mixture was stirred overnight at room temperature and then 10 ml
of water were added to the solution. Dichloromethane (150 ml) was
then added to the solution and the solution was washed with water.
The organic layer was dried over Na2SO4 and then evaporated
to near dryness. The residual material was purified by silica
gel column chromatography with dichloromethane containing
methanol (9 : 1, CH2Cl2–MeOH, v/v). Yield, 23% (0.57 g); TLC
(9 : 1, CH2Cl2–MeOH, v/v), Rf 0.29; 1H-NMR (DMSO-d6): 3.59
(m, 1H, 5ꢀ-CH2), 3.78 (m, 1H, 5ꢀ-CH2), 4.07 (m, 1H, 4ꢀ-CH), 4.50
(m, 1H, 3ꢀ-CH), 4.79 (dd, 1H, 2ꢀ-CH), 5.16 (d, 1H, CH2-pyrene),
5.43 (d, 1H, CH2-pyrene), 5.52 (d, 1H, 3ꢀ-OH), 6.11 (d, 1H, 1ꢀ-
CH), 7.30 (s, 2H, NH2), 7.95–8.24 (m, total 9H, pyrene), 8.32 (s,
1H, adenine) and 8.51 (s, 1H, adenine).
5ꢀ -Dimethoxytrityl-2ꢀ -O-(pyren-1-ylmethyl)-N-benzoyl-adeno-
sine, 3ꢀ-{(2-cyanoethyl)-(N,N -diisopropyl)}-phosphoramidite (4).
2-Cyanoethyl-N,N,N ꢀ,Nꢀ-tetraisopropylphosphateamidite (0.07 ml,
0.2 mmol) was added to a solution of 3 (0.13 g, 0.15 mmol) and
tetrazole (0.01 g, 0.15 mmol) in dry dichloromethane (1 mL).
The solution was stirred for 2 h at room temperature and
then dichloromethane (5 ml) was added to the solution. The
solution was washed with 10% NaHCO3 aqueous solution,
dried over Na2SO4 and then evaporated to near dryness. The
product 4 was purified by silica gel column chromatography with
dichloromethane containing ethyl acetate and triethylamine (45 :
45 : 10, CH2Cl2–AcOEt–Et3N, v/v). Yield, 89% (0.31 g); TLC (45 :
45 : 10, CH2Cl2–AcOEt–Et3N, v/v), Rf 0.75.
2ꢀ-O-(Pyren-1-ylmethyl)-cytidine (5). 1-Pyrenyl methyl chlo-
ride (2.0 g, 8.0 mmol) was added to a solution of cytidine (2.9 g,
12.0 mmol) and NaH (0.43 g) in DMF (60 ml) at 0 ◦C. The reaction
mixture was stirred overnight at room temperature and then 10 ml
of water were added to the solution. Dichloromethane (150 ml) was
then added to the solution and the solution was washed with water.
The organic layer was dried over Na2SO4 and then evaporated
to near dryness. The residual material was purified by silica
gel column chromatography with dichloromethane containing
methanol (9 : 1, CH2Cl2–MeOH, v/v). Yield, 44% (1.62 g); TLC
(9 : 1, CH2Cl2–MeOH, v/v), Rf 0.33; 1H-NMR (DMSO-d6): 3.60
(m, 1H, 5ꢀ-CH2), 3.69 (m, 1H, 5ꢀ-CH2), 3.93 (m, 1H, 4ꢀ-CH), 4.07
(dd, 1H, 2ꢀ-CH), 4.19 (m, 1H, 3ꢀ-CH), 5.11 (m, 1H, 5ꢀ-OH), 5.22 (d,
1H, 3ꢀ-OH), 5.24 (d, 1H, CH2-pyrene), 5.39 (d, 1H, CH2-pyrene),
5.67 (d, 1H, cytosine), 6.06 (d, 1H, 1ꢀ-CH), 7.16 (s, 2H, NH2), 7.90
(d, 1H, cytosine) and 8.08–8.31 (m, total 9H, aromatic of pyrene).
2ꢀ-O-(Pyren-1-ylmethyl)-N-benzoyl-adenosine (2). Trimethyl-
silyl chloride (0.66 ml, 5.19 mmol) was added to a solution
of 1 (0.5 g, 1.04 mmol), which was dried by coevaporation
with pyridine three times, in pyridine (10 ml). After stirring for
30 min, benzoyl chloride (0.36 ml, 3.1 mmol) was added to the
solution. The solution was stirred for 7 h at room temperature, and
10 ml of 28% NH3 aqueous solution was added to the solution.
After stirring for 1 h, the solution was concentrated to near
dryness. The residual material was dissolved in dichloromethane
(150 ml) and was then washed with water. The organic phase
was dried over Na2SO4 and then evaporated to near dryness. The
product 2 was purified by silica gel column chromatography with
dichloromethane containing methanol (9 : 1, CH2Cl2–MeOH,
v/v). Yield, 93% (0.90 g); TLC (9 : 1, CH2Cl2–MeOH, v/v), Rf
1
0.56; H-NMR (DMSO-d6): 3.61 (m, 1H, 5ꢀ-CH2), 3.69 (m, 1H,
5ꢀ-CH2), 4.09 (m, 1H, 4ꢀ-CH), 4.53 (m, 1H, 3ꢀ-CH), 4.83 (dd, 1H,
2ꢀ-CH), 5.19–5.21 (m, total 2H, 5ꢀ-OH and CH2-pyrene), 5.50 (d,
1H, CH2-pyrene), 5.60 (d, 1H, 3ꢀ-OH), 6.23 (d, 1H, 1ꢀ-CH), 7.56
(dd, 2H, aromatic of benzoyl), 7.62 (dd, 1H, aromatic of benzoyl),
7.96–8.26 (m, total 11H, aromatic of benzoyl and pyrene), 8.54 (s,
1H, adenine), 8.59 (s, 1H, adenine) and 11.09 (s, 1H, amide).
2ꢀ-O-(Pyren-1-ylmethyl)-N-benzoyl-cytidine (6). Trimethylsi-
lyl chloride (0.69 ml, 5.45 mmol) was added to a solution of 5
(0.5 g, 1.1 mmol), which was dried by coevaporation with pyridine
three times, in pyridine (10 ml). After stirring for 30 min, benzoyl
chloride (0.38 ml, 3.3 mmol) was added to the solution. The
solution was stirred for 7 h at room temperature, and then 10 ml of
This journal is
The Royal Society of Chemistry 2007
Org. Biomol. Chem., 2007, 5, 1945–1951 | 1949
©